APO RESEARCH · REPORT
Direct-to-consumer Genetic Testing
Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional. Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient's permission and then order the desired test. DTC genetic tests, however, allow consumers to bypass this process and order DNA tests themselves.
Product & engineering
Understand the product.
Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional. Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient's permission and then order the desired test. DTC genetic tests, however, allow consumers to bypass this process and order DNA tests themselves.
Selected research
Industry Research
Direct-to-consumer Genetic Testing Industry Research Report 2026
Market perspective
Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional. Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient's permission and then order the desired test. DTC genetic tests, however, allow consumers to bypass this process and order DNA tests themselves.
Global direct-to-consumer genetic testing main players include 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 60%. As for the types of products, it can be divided into diagnostic screening, preimplantation genetic diagnosis (PGD) and relationship testing. The most common product is relationship testing, with a share over 55%. In terms of applications, it is widely used in online and offline. Online is the largest application, holding a share over 68%.
Report Scope
Read the full market overview
This report quantifies the global Direct-to-consumer Genetic Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Direct-to-consumer Genetic Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Direct-to-consumer Genetic Testing Market by Company
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
Direct-to-consumer Genetic Testing Segment by Type
Diagnostic Screening
Preimplantation Genetic Diagnosis (PGD)
Relationship Testing
Direct-to-consumer Genetic Testing Segment by Application
Online Direct-to-consumer Genetic Testing
Offline Direct-to-consumer Genetic Testing
Direct-to-consumer Genetic Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Direct-to-consumer Genetic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Direct-to-consumer Genetic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Direct-to-consumer Genetic Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Direct-to-consumer Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diagnostic Screening
- Preimplantation Genetic Diagnosis (PGD)
- Relationship Testing
Applications
- Online Direct-to-consumer Genetic Testing
- Offline Direct-to-consumer Genetic Testing
Companies covered
- 23andMe
- MyHeritage
- LabCorp
- Myriad Genetics
- Ancestry.com
- Quest Diagnostics
- Gene By Gene
- DNA Diagnostics Center
- Invitae
- IntelliGenetics
- Ambry Genetics
- Living DNA
- EasyDNA
- Pathway Genomics
- Centrillion Technology
- Xcode
- Color Genomics
- Anglia DNA Services
- African Ancestry
- Canadian DNA Services
- DNA Family Check
- Alpha Biolaboratories
- Test Me DNA
- 23 Mofang
- Genetic Health
- DNA Services of America
- Shuwen Health Sciences
- Mapmygenome
- Full Genomes
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Direct-to-consumer Genetic Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Diagnostic Screening
- 2.2.3 Preimplantation Genetic Diagnosis (PGD)
- 2.2.4 Relationship Testing
- 2.3 Direct-to-consumer Genetic Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Online Direct-to-consumer Genetic Testing
- 2.3.3 Offline Direct-to-consumer Genetic Testing
- 2.4 Assumptions and Limitations
3 Direct-to-consumer Genetic Testing Breakdown Data by Type
- 3.1 Global Direct-to-consumer Genetic Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Direct-to-consumer Genetic Testing Forecasted Market Size by Type (2027-2032)
4 Direct-to-consumer Genetic Testing Breakdown Data by Application
- 4.1 Global Direct-to-consumer Genetic Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Direct-to-consumer Genetic Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Direct-to-consumer Genetic Testing Market Perspective (2021-2032)
- 5.2 Global Direct-to-consumer Genetic Testing Growth Trends by Region
- 5.2.1 Global Direct-to-consumer Genetic Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Direct-to-consumer Genetic Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Direct-to-consumer Genetic Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Direct-to-consumer Genetic Testing Market Dynamics
- 5.3.1 Direct-to-consumer Genetic Testing Industry Trends
- 5.3.2 Direct-to-consumer Genetic Testing Market Drivers
- 5.3.3 Direct-to-consumer Genetic Testing Market Challenges
- 5.3.4 Direct-to-consumer Genetic Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Direct-to-consumer Genetic Testing Players by Revenue
- 6.1.1 Global Top Direct-to-consumer Genetic Testing Players by Revenue (2021-2026)
- 6.1.2 Global Direct-to-consumer Genetic Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Direct-to-consumer Genetic Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Direct-to-consumer Genetic Testing Head Office and Area Served
- 6.4 Global Direct-to-consumer Genetic Testing Players, Product Type & Application
- 6.5 Global Direct-to-consumer Genetic Testing Manufacturers Established Date
- 6.6 Global Direct-to-consumer Genetic Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Direct-to-consumer Genetic Testing Market Size (2021-2032)
- 7.2 North America Direct-to-consumer Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Direct-to-consumer Genetic Testing Market Size by Country (2021-2026)
- 7.4 North America Direct-to-consumer Genetic Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Direct-to-consumer Genetic Testing Market Size (2021-2032)
- 8.2 Europe Direct-to-consumer Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Direct-to-consumer Genetic Testing Market Size by Country (2021-2026)
- 8.4 Europe Direct-to-consumer Genetic Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Direct-to-consumer Genetic Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Direct-to-consumer Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Direct-to-consumer Genetic Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Direct-to-consumer Genetic Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Direct-to-consumer Genetic Testing Market Size (2021-2032)
- 10.2 South America Direct-to-consumer Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Direct-to-consumer Genetic Testing Market Size by Country (2021-2026)
- 10.4 South America Direct-to-consumer Genetic Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Direct-to-consumer Genetic Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Direct-to-consumer Genetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Direct-to-consumer Genetic Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Direct-to-consumer Genetic Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 23andMe
- 12.1.1 23andMe Company Information
- 12.1.2 23andMe Business Overview
- 12.1.3 23andMe Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.1.4 23andMe Direct-to-consumer Genetic Testing Product Portfolio
- 12.1.5 23andMe Recent Developments
- 12.2 MyHeritage
- 12.2.1 MyHeritage Company Information
- 12.2.2 MyHeritage Business Overview
- 12.2.3 MyHeritage Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.2.4 MyHeritage Direct-to-consumer Genetic Testing Product Portfolio
- 12.2.5 MyHeritage Recent Developments
- 12.3 LabCorp
- 12.3.1 LabCorp Company Information
- 12.3.2 LabCorp Business Overview
- 12.3.3 LabCorp Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.3.4 LabCorp Direct-to-consumer Genetic Testing Product Portfolio
- 12.3.5 LabCorp Recent Developments
- 12.4 Myriad Genetics
- 12.4.1 Myriad Genetics Company Information
- 12.4.2 Myriad Genetics Business Overview
- 12.4.3 Myriad Genetics Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.4.4 Myriad Genetics Direct-to-consumer Genetic Testing Product Portfolio
- 12.4.5 Myriad Genetics Recent Developments
- 12.5 Ancestry.com
- 12.5.1 Ancestry.com Company Information
- 12.5.2 Ancestry.com Business Overview
- 12.5.3 Ancestry.com Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.5.4 Ancestry.com Direct-to-consumer Genetic Testing Product Portfolio
- 12.5.5 Ancestry.com Recent Developments
- 12.6 Quest Diagnostics
- 12.6.1 Quest Diagnostics Company Information
- 12.6.2 Quest Diagnostics Business Overview
- 12.6.3 Quest Diagnostics Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.6.4 Quest Diagnostics Direct-to-consumer Genetic Testing Product Portfolio
- 12.6.5 Quest Diagnostics Recent Developments
- 12.7 Gene By Gene
- 12.7.1 Gene By Gene Company Information
- 12.7.2 Gene By Gene Business Overview
- 12.7.3 Gene By Gene Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.7.4 Gene By Gene Direct-to-consumer Genetic Testing Product Portfolio
- 12.7.5 Gene By Gene Recent Developments
- 12.8 DNA Diagnostics Center
- 12.8.1 DNA Diagnostics Center Company Information
- 12.8.2 DNA Diagnostics Center Business Overview
- 12.8.3 DNA Diagnostics Center Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.8.4 DNA Diagnostics Center Direct-to-consumer Genetic Testing Product Portfolio
- 12.8.5 DNA Diagnostics Center Recent Developments
- 12.9 Invitae
- 12.9.1 Invitae Company Information
- 12.9.2 Invitae Business Overview
- 12.9.3 Invitae Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.9.4 Invitae Direct-to-consumer Genetic Testing Product Portfolio
- 12.9.5 Invitae Recent Developments
- 12.10 IntelliGenetics
- 12.10.1 IntelliGenetics Company Information
- 12.10.2 IntelliGenetics Business Overview
- 12.10.3 IntelliGenetics Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.10.4 IntelliGenetics Direct-to-consumer Genetic Testing Product Portfolio
- 12.10.5 IntelliGenetics Recent Developments
- 12.11 Ambry Genetics
- 12.11.1 Ambry Genetics Company Information
- 12.11.2 Ambry Genetics Business Overview
- 12.11.3 Ambry Genetics Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.11.4 Ambry Genetics Direct-to-consumer Genetic Testing Product Portfolio
- 12.11.5 Ambry Genetics Recent Developments
- 12.12 Living DNA
- 12.12.1 Living DNA Company Information
- 12.12.2 Living DNA Business Overview
- 12.12.3 Living DNA Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.12.4 Living DNA Direct-to-consumer Genetic Testing Product Portfolio
- 12.12.5 Living DNA Recent Developments
- 12.13 EasyDNA
- 12.13.1 EasyDNA Company Information
- 12.13.2 EasyDNA Business Overview
- 12.13.3 EasyDNA Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.13.4 EasyDNA Direct-to-consumer Genetic Testing Product Portfolio
- 12.13.5 EasyDNA Recent Developments
- 12.14 Pathway Genomics
- 12.14.1 Pathway Genomics Company Information
- 12.14.2 Pathway Genomics Business Overview
- 12.14.3 Pathway Genomics Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.14.4 Pathway Genomics Direct-to-consumer Genetic Testing Product Portfolio
- 12.14.5 Pathway Genomics Recent Developments
- 12.15 Centrillion Technology
- 12.15.1 Centrillion Technology Company Information
- 12.15.2 Centrillion Technology Business Overview
- 12.15.3 Centrillion Technology Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.15.4 Centrillion Technology Direct-to-consumer Genetic Testing Product Portfolio
- 12.15.5 Centrillion Technology Recent Developments
- 12.16 Xcode
- 12.16.1 Xcode Company Information
- 12.16.2 Xcode Business Overview
- 12.16.3 Xcode Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.16.4 Xcode Direct-to-consumer Genetic Testing Product Portfolio
- 12.16.5 Xcode Recent Developments
- 12.17 Color Genomics
- 12.17.1 Color Genomics Company Information
- 12.17.2 Color Genomics Business Overview
- 12.17.3 Color Genomics Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.17.4 Color Genomics Direct-to-consumer Genetic Testing Product Portfolio
- 12.17.5 Color Genomics Recent Developments
- 12.18 Anglia DNA Services
- 12.18.1 Anglia DNA Services Company Information
- 12.18.2 Anglia DNA Services Business Overview
- 12.18.3 Anglia DNA Services Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.18.4 Anglia DNA Services Direct-to-consumer Genetic Testing Product Portfolio
- 12.18.5 Anglia DNA Services Recent Developments
- 12.19 African Ancestry
- 12.19.1 African Ancestry Company Information
- 12.19.2 African Ancestry Business Overview
- 12.19.3 African Ancestry Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.19.4 African Ancestry Direct-to-consumer Genetic Testing Product Portfolio
- 12.19.5 African Ancestry Recent Developments
- 12.20 Canadian DNA Services
- 12.20.1 Canadian DNA Services Company Information
- 12.20.2 Canadian DNA Services Business Overview
- 12.20.3 Canadian DNA Services Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.20.4 Canadian DNA Services Direct-to-consumer Genetic Testing Product Portfolio
- 12.20.5 Canadian DNA Services Recent Developments
- 12.21 DNA Family Check
- 12.21.1 DNA Family Check Company Information
- 12.21.2 DNA Family Check Business Overview
- 12.21.3 DNA Family Check Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.21.4 DNA Family Check Direct-to-consumer Genetic Testing Product Portfolio
- 12.21.5 DNA Family Check Recent Developments
- 12.22 Alpha Biolaboratories
- 12.22.1 Alpha Biolaboratories Company Information
- 12.22.2 Alpha Biolaboratories Business Overview
- 12.22.3 Alpha Biolaboratories Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.22.4 Alpha Biolaboratories Direct-to-consumer Genetic Testing Product Portfolio
- 12.22.5 Alpha Biolaboratories Recent Developments
- 12.23 Test Me DNA
- 12.23.1 Test Me DNA Company Information
- 12.23.2 Test Me DNA Business Overview
- 12.23.3 Test Me DNA Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.23.4 Test Me DNA Direct-to-consumer Genetic Testing Product Portfolio
- 12.23.5 Test Me DNA Recent Developments
- 12.24 23 Mofang
- 12.24.1 23 Mofang Company Information
- 12.24.2 23 Mofang Business Overview
- 12.24.3 23 Mofang Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.24.4 23 Mofang Direct-to-consumer Genetic Testing Product Portfolio
- 12.24.5 23 Mofang Recent Developments
- 12.25 Genetic Health
- 12.25.1 Genetic Health Company Information
- 12.25.2 Genetic Health Business Overview
- 12.25.3 Genetic Health Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.25.4 Genetic Health Direct-to-consumer Genetic Testing Product Portfolio
- 12.25.5 Genetic Health Recent Developments
- 12.26 DNA Services of America
- 12.26.1 DNA Services of America Company Information
- 12.26.2 DNA Services of America Business Overview
- 12.26.3 DNA Services of America Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.26.4 DNA Services of America Direct-to-consumer Genetic Testing Product Portfolio
- 12.26.5 DNA Services of America Recent Developments
- 12.27 Shuwen Health Sciences
- 12.27.1 Shuwen Health Sciences Company Information
- 12.27.2 Shuwen Health Sciences Business Overview
- 12.27.3 Shuwen Health Sciences Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.27.4 Shuwen Health Sciences Direct-to-consumer Genetic Testing Product Portfolio
- 12.27.5 Shuwen Health Sciences Recent Developments
- 12.28 Mapmygenome
- 12.28.1 Mapmygenome Company Information
- 12.28.2 Mapmygenome Business Overview
- 12.28.3 Mapmygenome Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.28.4 Mapmygenome Direct-to-consumer Genetic Testing Product Portfolio
- 12.28.5 Mapmygenome Recent Developments
- 12.29 Full Genomes
- 12.29.1 Full Genomes Company Information
- 12.29.2 Full Genomes Business Overview
- 12.29.3 Full Genomes Revenue in Direct-to-consumer Genetic Testing Business (2021-2026)
- 12.29.4 Full Genomes Direct-to-consumer Genetic Testing Product Portfolio
- 12.29.5 Full Genomes Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst